These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6967296)

  • 1. 5-epi-Sisomicin and 5-epi-Gentamicin B: substrates for aminoglycoside-modifying enzymes that retain activity against aminoglycoside-resistant bacteria.
    Vastola AP; Altschaefl J; Harford S
    Antimicrob Agents Chemother; 1980 May; 17(5):798-802. PubMed ID: 6967296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.
    Almaghrabi R; Clancy CJ; Doi Y; Hao B; Chen L; Shields RK; Press EG; Iovine NM; Townsend BM; Wagener MM; Kreiswirth B; Nguyen MH
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4443-51. PubMed ID: 24867988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
    Kabins SA; Nathan C; Cohen S
    Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes.
    Cox G; Ejim L; Stogios PJ; Koteva K; Bordeleau E; Evdokimova E; Sieron AO; Savchenko A; Serio AW; Krause KM; Wright GD
    ACS Infect Dis; 2018 Jun; 4(6):980-987. PubMed ID: 29634241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of netilmicin, a new aminoglycoside antibiotic, compared with that of gentamicin.
    Phillips I; Smith A; Shannon K
    Antimicrob Agents Chemother; 1977 Mar; 11(3):402-6. PubMed ID: 301004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
    Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE; Packer RR
    Antimicrob Agents Chemother; 1980 Aug; 18(2):338-45. PubMed ID: 7447410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparative activity of kanamycin, gentamicin and sisomicin--a new aminoglycoside, against clinical isolates.
    Lakshmi N; Kumar AG
    Indian J Pathol Microbiol; 1989 Jul; 32(3):207-12. PubMed ID: 2777351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of dactimicin in vitro compared with that of dibekacin, netilmicin, sisomicin and micronomicin.
    Inouye S; Hara T; Matsuhashi Y; Kitasato I
    Drugs Exp Clin Res; 1989; 15(10):455-63. PubMed ID: 2632214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of 5-episisomicin in bacteria resistant to other aminoglycoside antibiotics.
    Kabins SA; Nathan C
    Antimicrob Agents Chemother; 1978 Sep; 14(3):391-7. PubMed ID: 101131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of dactimicin to aminoglycoside-modifying enzymes.
    Gomez-Lus R; Marco MA; Gomez-Lus ML
    Drugs Exp Clin Res; 1987; 13(12):731-5. PubMed ID: 3447876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the 1- N-(4-Amino-2 S-hydroxybutyryl) and 6'- N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity, and Antibacterial Activity in the Sisomicin Class of Aminoglycoside Antibiotics.
    Sonousi A; Sarpe VA; Brilkova M; Schacht J; Vasella A; Böttger EC; Crich D
    ACS Infect Dis; 2018 Jul; 4(7):1114-1120. PubMed ID: 29708331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin.
    Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1977 Jan; 11(1):118-21. PubMed ID: 836009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
    Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
    Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside-modifying enzymes in high-level streptomycin and gentamicin resistant Enterococcus spp. in Spain.
    del Campo R; Tenorio C; Rubio C; Castillo J; Torres C; Gómez-Lus R
    Int J Antimicrob Agents; 2000 Aug; 15(3):221-6. PubMed ID: 10926445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of (methyl-14C)-sisomicin and (methyl-14C)-gentamicin into bacterial cells.
    Lee BK; Condon RG; Munayyer H; Weinstein MJ
    J Antibiot (Tokyo); 1978 Feb; 31(2):141-6. PubMed ID: 416011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside.
    Waitz JA; Miller GH; Moss E; Chiu PJ
    Antimicrob Agents Chemother; 1978 Jan; 13(1):41-8. PubMed ID: 626490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications.
    Kondo S; Hotta K
    J Infect Chemother; 1999 Mar; 5(1):1-9. PubMed ID: 11810483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
    Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K
    J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.